Nayeem Sara M. 4
4 · Mersana Therapeutics, Inc. · Filed Jan 4, 2018
Insider Transaction Report
Form 4
Nayeem Sara M.
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-02+3,560→ 3,560 totalExercise: $17.39Exp: 2028-01-02→ Common Stock (3,560 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in equal quarterly installments on the last day of each calendar quarter of 2018.